Iris

Hey there! I'm Orris, your AI assistant. How can I help you today?

Immune reconstitution inflammatory syndrome

Reading File
Searching PubMed

immune reconstitution inflammatory syndrome IRIS

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have rich, comprehensive content from multiple authoritative textbooks. Here is the full, synthesized answer:

Immune Reconstitution Inflammatory Syndrome (IRIS)

Definition

IRIS is a paradoxical worsening of clinical status that occurs when a previously severely immunosuppressed patient's immune system begins to recover. It manifests as an exuberant, often disorganized host inflammatory response to previously recognized or subclinical antigens. The syndrome most commonly develops after initiation of antiretroviral therapy (ART) in HIV-infected patients. - Murray & Nadel's Textbook of Respiratory Medicine, p. 2866

Types

TypeDescription
Paradoxical IRISPatient has a known infection, responds to treatment, then paradoxically worsens after starting ART
Unmasking IRISPatient starts ART without a known infection; immune recovery reveals a previously subclinical (silent) infection
  • Fishman's Pulmonary Diseases and Disorders, p. 2371-2372

Pathogenesis

IRIS is thought to result from:
  1. Dysregulation of rising CD4+ T cells that are highly antigen-specific, mounting a disproportionate inflammatory response
  2. Hyperresponsiveness of the innate immune system to helper T cells
  3. In cryptococcal IRIS specifically: pre-ART elevations in Th2 and Th17 cytokines (IL-17, IL-4), reduced pro-inflammatory cytokines (TNF-alpha, G-CSF), and high titers of serum/CSF cryptococcal antigen
There is an inverse correlation between baseline CD4 count and the probability of developing IRIS - lower CD4 counts at ART initiation mean higher IRIS risk. - Firestein & Kelley's Textbook of Rheumatology

Risk Factors

  • CD4 count <50-100 cells/μL at ART initiation (greatest risk below 50 cells/μL)
  • Initiating ART shortly after diagnosing an opportunistic infection
  • Rapid virologic and immunologic response to ART
  • High pathogen burden at time of ART initiation
  • IRIS can also occur in transplant recipients when immunosuppressive therapy is withdrawn rapidly

Timing

The majority of cases occur within the first 1-3 months after ART initiation, though cases can present several months later. - Murray & Nadel's, p. 2866

Common Triggers / Associated Conditions

Infections (most common):
  • Mycobacteria - M. tuberculosis and MAC are the most frequently encountered
  • Fungal - Cryptococcus (especially meningitis), PCP (Pneumocystis)
  • Viral - CMV
  • Leprosy (can flare after ART initiation)
Non-infectious:
  • Sarcoidosis (may be unmasked or worsen)
  • Autoimmune diseases appearing de novo: RA, SLE, polymyositis, autoimmune hepatitis, Guillain-Barre syndrome, adult-onset Still's disease
  • Malignancies - tumors may paradoxically worsen
  • Cerebral CD8 lymphocytosis, alopecia universalis, terminal ileitis
  • Firestein & Kelley's Textbook of Rheumatology; Murray & Nadel's Respiratory Medicine

Diagnostic Criteria

All of the following should be present:
  1. Diagnosis of AIDS
  2. Currently on ART with evidence of increase in CD4 count and decrease in HIV viral load
  3. Exaggerated inflammatory response to infection
  4. Inflammatory symptoms appearing during ART that cannot be explained by another cause (other opportunistic infections, drug toxicity, treatment failure)
  • Firestein & Kelley's Textbook of Rheumatology, p. 6620-6622

Special Considerations: Cryptococcal Meningitis-IRIS

This warrants particular caution because the CNS has limited anatomical flexibility, making IRIS here more lethal than extra-CNS IRIS.
  • Deferring ART by 4-5 weeks (rather than starting immediately) after diagnosing cryptococcal meningitis is associated with significantly improved survival, especially in patients with few CSF white cells
  • This is the one important exception to the general rule of starting ART as soon as possible after diagnosing an OI
  • Screening for cryptococcal antigen (CrAg) in asymptomatic patients with CD4 <100 cells/mm³ before starting ART is WHO-recommended to prevent unmasking IRIS
  • Goldman-Cecil Medicine; Fishman's Pulmonary Diseases, p. 2373-2375

TB-IRIS and the PredART Trial

  • Prophylactic prednisone reduces the risk of TB-associated IRIS in high-risk individuals (CD4 <100 cells/μL, within 30 days of TB treatment initiation)
  • Regimen: prednisone 40 mg/day x 14 days, then 20 mg/day x 14 days
  • This was established in the PredART Clinical Trial, without increased risk of other severe infections or cancers
  • TB-IRIS may contribute to long-term spirometric abnormalities in HIV/TB patients
  • Murray & Nadel's Respiratory Medicine, p. 2866

Management

SeverityManagement
Mild IRISContinue ART; supportive care only
Moderate IRISNSAIDs to reduce inflammation
Severe IRIS (CNS, airway compromise)Corticosteroids (prednisone 1.5 mg/kg/day x 2 weeks, then 0.75 mg/kg/day x 2 weeks)
Cryptococcal meningitis IRIS with raised ICP/cerebral edemaCorticosteroids under expert guidance (though steroids are otherwise unhelpful or detrimental in cryptococcal disease)
  • ART should generally be continued in patients who develop IRIS; stopping is rarely necessary
  • Carefully consider each case individually; expert consultation recommended
  • JAK inhibitors - a recent clinical trial suggests they may be effective in preventing inflammatory complications of ART (emerging evidence)
  • Murray & Nadel's Respiratory Medicine, p. 2866; Goldman-Cecil Medicine; Firestein & Kelley's Rheumatology, p. 6630

Key Points Summary

FeatureDetail
SettingHIV/AIDS patients starting ART; also post-transplant on reduced immunosuppression
TimingTypically 1-3 months after ART initiation
HallmarkParadoxical worsening despite improving CD4/viral load
Biggest risk factorCD4 <50 cells/μL at ART initiation
Most common triggersM. tuberculosis, MAC, Cryptococcus, PCP
Most dangerous manifestationCryptococcal meningitis-IRIS (CNS, high mortality)
Prevention (TB-IRIS)Prophylactic prednisone (PredART protocol)
Prevention (Crypto-IRIS)Delay ART 4-5 weeks; CrAg screening
Treatment backboneContinue ART + steroids for severe cases
This is a shared conversation. Sign in to Orris to start your own chat.